We are live on ! Find out more
SM

SB Management Portfolio holdings

AUM $516M Turnover 23.08%
1-Year Est. Return 40.71%
This Fund
S&P 500
This Quarter Est. Return
-22.58%
1 Year Est. Return
-40.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$516M
AUM Growth
-$496M
Cap. Flow
-$237M
Cap. Flow %
-45.9%
Top 10 Hldgs %
99.28%
Holding
26
New
–
Increased
–
Reduced
3
Closed
6
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.7 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$72.2M
2
CPUH
Compute Health Acquisition Corp.
CPUH
+$38.9M
3
SANA icon
Sana Biotechnology
SANA
+$34.2M
4
REVH
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
+$29.2M
5
LYEL icon
Lyell Immunopharma
LYEL
+$27.1M

Sector Composition

Rank Sector Weight
1 Healthcare 57.01%
2 Miscellaneous 24.33%
3 Consumer Discretionary 7.75%
4 Financials 7.07%
5 Industrials 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$178M 34.57%
43,176,600
– –
2021 Q2
3 quarters
LCW.U icon
2
DELISTED
Learn CW Investment Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
LCW.U
$100M 19.39%
10,000,000
– –
2021 Q4
1 quarter
ABCL icon
3
AbCellera Biologics
ABCL
$3.86B
$75.7M 14.68%
7,764,299
-2,052,891
-21% -$19.4M
2020 Q4
5 quarters
SSU
4
DELISTED
SIGNA Sports United N.V.
SSU
$40M 7.75%
5,000,000
– –
2021 Q4
1 quarter
BETR icon
5
Better Home & Finance Holding
BETR
$197M
$26.6M 5.16%
54,000
– –
2021 Q3
2 quarters
WGS icon
6
GeneDx Holdings
WGS
$1.92B
$22.9M 4.43%
225,771
-47,609
-17% -$5.29M
2021 Q1
4 quarters
SVFAU
7
DELISTED
SVF Investment Corp. Unit
SVFAU
$21.8M 4.23%
2,200,000
– –
2021 Q1
4 quarters
SYM icon
8
Symbotic
SYM
$5.08B
$19.8M 3.84%
2,000,000
– –
2021 Q1
4 quarters
PACB icon
9
Pacific Biosciences
PACB
$553M
$17.2M 3.33%
1,886,107
-6,270,000
-77% -$72.2M
2020 Q4
5 quarters
SVFB
10
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$9.8M 1.91%
1,000,000
– –
2021 Q1
4 quarters
EOCW.WS
11
CALL
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$742K 0.14%
1,237,500
– –
2021 Q3
2 quarters
EQRXW
12
CALL
DELISTED
EQRx, Inc. Warrant
EQRXW
$696K 0.13%
800,000
– –
2021 Q2
3 quarters
HERAW
13
CALL
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$556K 0.11%
1,250,000
– –
2021 Q2
3 quarters
CPUH.WS
14
CALL
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$485K 0.09%
1,000,000
– –
2021 Q2
3 quarters
BETRW icon
15
CALL
Better Home & Finance Warrant
BETRW
$1.84M
$276K 0.05%
675,000
– –
2021 Q3
2 quarters
REVHW
16
CALL
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$270K 0.05%
600,000
– –
2021 Q2
3 quarters
FTAAW
17
CALL
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$262K 0.05%
500,000
– –
2021 Q2
3 quarters
PACXW
18
CALL
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$185K 0.04%
916,666
– –
2021 Q2
3 quarters
BWCAW
19
CALL
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$125K 0.02%
249,500
– –
2021 Q4
1 quarter
SCVX.WS
20
CALL
DELISTED
SCVX Corp.
SCVX.WS
$99K 0.02%
500,000
– –
2021 Q3
2 quarters
LYEL icon
21
Lyell Immunopharma
LYEL
$212M
– –
-175,000
Closed -$27.1M –
NRDY icon
22
Nerdy
NRDY
$51.3M
– –
-11,000
Closed -$743K –
SANA icon
23
Sana Biotechnology
SANA
$686M
– –
-2,209,004
Closed -$34.2M –
BWC
24
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
– –
-998,000
Closed -$9.7M –
CPUH
25
DELISTED
Compute Health Acquisition Corp.
CPUH
– –
-4,000,000
Closed -$38.9M –
1
2

Similar funds

GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return
HT
Hefren-Tillotson Pittsburgh, Pennsylvania $523M AUM 4.13% 1-Year Est. Return
HAM
HHR Asset Management Berkeley Heights, New Jersey $552M AUM 15.61% 1-Year Est. Return
FC
Ferris Capital Marlborough, Massachusetts $437M AUM 8.6% 1-Year Est. Return
FC
Full18 Capital Westport, Connecticut $434M AUM 5.79% 1-Year Est. Return
VR
Viridian RIA Bothell, Washington $430M AUM 6.31% 1-Year Est. Return
MCM
Model Capital Management Wellesley, Massachusetts $422M AUM 2.75% 1-Year Est. Return
TM
THRC Management Cisco, Texas $634M AUM

SB Management's Q1 2022 Portfolio in Review

As of Q1 2022, SB Management held 26 positions worth $516M, down 49% from $1.01B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

SB Management withdrew a net $237M in Q1 2022, closing 6 positions and reducing 3 holdings. Its most notable exit was Compute Health Acquisition Corp., an estimated $38.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 70% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • SB Management's biggest Q1 2022 reduction was Pacific Biosciences, cutting an estimated $72.2M.
  • SB Management fully exited Compute Health Acquisition Corp. in Q1 2022, selling an estimated $38.9M.
  • SB Management's ten largest holdings make up 99% of its $516M portfolio in Q1 2022.
  • SB Management opened 0 new positions and closed 6 in Q1 2022.
  • SB Management's portfolio value fell 49% quarter-over-quarter to $516M.

Based on SB Management's 13F filing for Q1 2022, filed 16 May 2022.